09-Jun-2008 - Sartorius Stedim Biotech has teamed up with Wuxi AppTec to help companies remove some of the strain of carrying out viral clearance testing, which for large biopharmaceutical companies can carry a price tag of up to $1m a year.
21-Apr-2008 - in-PharmaTechnologist.com's periodic round-up of developments in the pharmaceutical manufacturing space includes news of three new facilities, plus some interesting product launches and updates.
17-Mar-2008 - A successful and strategically important year,' is how Sartorius CEO Joachim Kreuzburg described 2007, a year highlighted by merger of its biotechnology division with Stedim to boost its presence in the burgeoning biopharmaceutical market.
16-Jan-2008 - Processing specialist Sartorius Stedim Biotech today announced a cooperation and supply deal with systems manufacturing firm Paul Mueller Company for the US market, with a production facility in Pennsylvania set to close as a result.
15-Oct-2007 - Normally, they are green, sort of spongy and found in dank nooks and crannies - but mosses have now been designed as therapeutic protein producing factories and are being implemented on a grand scale.
06-Jun-2007 - Sartorius has signed a non-exclusive licensing deal with Dutch biotech firms Crucell and DSM for the use of their PER C6 cell culture technology which could result in the creation of a new bioprocessing platform combined with disposable technology.
10-Apr-2007 - Mar Cor Purification has bought GE Water and Process Technologies' dialysis water business for $30.6m (€22.8m) to become the largest provider of dialysis water in the US, and plans to expand their presence in industrial life science markets.